<DOC>
	<DOC>NCT00000809</DOC>
	<brief_summary>The purpose of this study is to test the safety and effectiveness of two different formulations of an HIV vaccine in infants born to HIV-infected women.</brief_summary>
	<brief_title>Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<mesh_term>QS 21</mesh_term>
	<criteria>Inclusion Criteria Infants may be eligible for this study if they: Are 1 to 3 days old.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>HIV Preventive Vaccine</keyword>
	<keyword>HIV Therapeutic Vaccine</keyword>
</DOC>